Ebetrex 100 mg/ ml Norge - norsk - Statens legemiddelverk

ebetrex 100 mg/ ml

ebewe pharma ges.m.b.h nfg. kg - metotreksatdinatrium - konsentrat til infusjonsvæske, oppløsning - 100 mg/ ml

Amaryl 4 mg Norge - norsk - Statens legemiddelverk

amaryl 4 mg

sanofi-aventis norge (3) - glimepirid - tablett - 4 mg

Amaryl 1 mg Norge - norsk - Statens legemiddelverk

amaryl 1 mg

sanofi-aventis norge (3) - glimepirid - tablett - 1 mg

Amaryl 2 mg Norge - norsk - Statens legemiddelverk

amaryl 2 mg

sanofi-aventis norge (3) - glimepirid - tablett - 2 mg

Amaryl 3 mg Norge - norsk - Statens legemiddelverk

amaryl 3 mg

sanofi-aventis norge (3) - glimepirid - tablett - 3 mg

Marcain 2.5 mg/ ml Norge - norsk - Statens legemiddelverk

marcain 2.5 mg/ ml

aspen pharma trading limited - bupivakainhydroklorid - injeksjonsvæske, oppløsning - 2.5 mg/ ml

Marcain 5 mg/ ml Norge - norsk - Statens legemiddelverk

marcain 5 mg/ ml

aspen pharma trading limited - bupivakainhydroklorid - injeksjonsvæske, oppløsning - 5 mg/ ml

Amaryl 2 mg Norge - norsk - Statens legemiddelverk

amaryl 2 mg

orifarm as - glimepirid - tablett - 2 mg

Amaryl 3 mg Norge - norsk - Statens legemiddelverk

amaryl 3 mg

orifarm as - glimepirid - tablett - 3 mg

Spikevax (previously COVID-19 Vaccine Moderna) Den europeiske union - norsk - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaksiner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.